Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Notes Payables (2025)

Treace Medical Concepts (TMCI) has disclosed Notes Payables for 1 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Notes Payables changed N/A year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Dec 2025, changed N/A, and an annual FY2025 reading of $1.7 million, changed N/A over the prior year.
  • Notes Payables was $1.7 million for Q4 2025 at Treace Medical Concepts, up from $1.1 million in the prior quarter.
  • Across five years, Notes Payables topped out at $1.7 million in Q4 2025 and bottomed at $1.1 million in Q2 2025.